Compare · ACCD vs OACB
ACCD vs OACB
Side-by-side comparison of Accolade Inc. (ACCD) and Oaktree Acquisition Corp. II (OACB): market cap, price performance, sector, and recent activity on the wire.
Summary
- ACCD operates in Consumer Discretionary, while OACB operates in Finance - the two are in different parts of the market.
- ACCD is the larger of the two at $1.18B, about 3.8x OACB ($308.1M).
- ACCD has more recent analyst coverage (25 ratings vs 1 for OACB).
- Company
- Accolade Inc.
- Oaktree Acquisition Corp. II
- Price
- $7.03+0.00%
- $9.40-1.05%
- Market cap
- $1.18B
- $308.1M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 25
- 1
Accolade Inc.
Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was founded in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Oaktree Acquisition Corp. II
Oaktree Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the industrial and consumer sectors. The company was incorporated in 2020 and is headquartered in Los Angeles, California.
Latest ACCD
- Defining Wellness Centers Names Bill Morrison Chief Financial Officer
- SEC Form 15-12G filed by Accolade Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Accolade Inc.
- SEC Form 25-NSE filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- SEC Form S-8 POS filed by Accolade Inc.
- Chief Executive Officer Singh Rajeev returned $10,429,525 worth of shares to the company (1,483,574 units at $7.03), closing all direct ownership in the company (SEC Form 4)
Latest OACB
- Certain Closed-end Funds Advised by Franklin Templeton Fund Adviser, LLC Announce Appointment of New Chair and Directors
- SEC Form 25 filed by Oaktree Acquisition Corp. II
- Stocks That Hit 52-Week Lows On Thursday
- Oaktree Acquisition Corp. II filed SEC Form 8-K: Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
- Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination
- Oaktree Acquisition Corp. II filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- Oaktree Acquisition Corp. II Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with Alvotech
- Stocks That Hit 52-Week Lows On Thursday
- Oaktree Acquisition Corp. II filed SEC Form 8-K: Other Events
- Oaktree Acquisition Corp. II Combination Partner Alvotech Highlights AVT04 Clinical Study